printlogo
http://www.ethz.ch/index_EN
Laboratorium für Organische Chemie
 
Sitemap |
print
  
Deutsch English

Prof. Dr. Jeffrey Bode

Demnächst

  • 01. Mar, 14:00-15:30, Noncovalent water-based assemblies: robustness, adaptivity, and function, Dr. Boris Rybtchinski, Intergroup Seminar, HCI H8.1
  • 05. Mar, 16:00-18:00, Privileged Chiral Spiro Catalysts, Prof. Dr. Qi Lin Zhou, Organic Colloquium, HCI J3

Laboratorium für Organische Chemie
HCI F315
Wolfgang Pauli Strasse 10
8093 Zürich

Tel. +41 44 633 21 03
Fax: +41 44 633 12 35

Email: bode@org.chem.ethz.ch

groupe-page


Since 2010, Jeffrey Bode is Professor of Synthetic Organic Chemisty at ETH–Zürich. His research group works on the development of new reactions and their application to the synthesis of small molecules and peptides, shapeshifting organic molecules, molecular diagnostics, and novel materials.

Jeffrey Bode was born in 1974 near Los Angeles, California. He studied Chemistry (B.S., 1996) and Philosophy (B.A., 1996) at Trinity University in San Antonio, Texas. He began his graduate work at the California Institute of Technology and moved with his research advisor, Prof. Erick Carreira, to ETH–Zürich in 1998, where he received his Dok. Nat. Sci. in 2001. From 2001–2003, he was a JSPS Postdoctoral Fellowship at the Tokyo Institute of Technology with Prof. Keisuke Suzuki. In 2003, he joined the University of California, Santa Barbara as an Assistant Professor of Chemistry and Biochemistry. In 2007, he moved to the University of Pennsylvania in Philadelphia as an Associate Professor before joining ETH-Zürich in 2010.

His research and teachning have been recognized by several awards including the Camille and Henry Dreyfus New Faculty Award (2003), NSF Career Award (2004), Beckman Young Investigator Award (2006), Research Corporation Cottrell Scholar Award (2006), David and Lucille Packard Foundation Fellowship (2006), Alfred P. Sloan Fellowship (2007), the ACS Cope Scholar Award (2008), and the Hirata Gold Medal (2009). He has received awards from pharmaceutical companies including Amgen, Astrazeneca, Bristol Myers Squibb, Eli Lilly, and Roche and was listed among the “Top 20 under 40 Brains in Science” by Discover Magazine (2008).

 

Wichtiger Hinweis:
Diese Website wird in älteren Versionen von Netscape ohne graphische Elemente dargestellt. Die Funktionalität der Website ist aber trotzdem gewährleistet. Wenn Sie diese Website regelmässig benutzen, empfehlen wir Ihnen, auf Ihrem Computer einen aktuellen Browser zu installieren. Weitere Informationen finden Sie auf
folgender Seite.

Important Note:
The content in this site is accessible to any browser or Internet device, however, some graphics will display correctly only in the newer versions of Netscape. To get the most out of our site we suggest you upgrade to a newer browser.
More information

© 2012 ETH Zurich | Imprint | Disclaimer | 9 September 2010
top